IR fluorescence imaging during staging laparoscopy for detecting metastases in pancreatic cancer
Phase 2
Recruiting
- Conditions
- C535836Pancreatic cancerPancreatic cancer, Staging laparoscopy
- Registration Number
- JPRN-jRCT1051180076
- Lead Sponsor
- Fukumoto Takumi
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Aged 20 or over and can provide written voluntary consent to participate
-Pathologically or clinically diagnosed as pancreatic cancer
-Radiographically non-metastatic disease
-Planned for the staging laparoscopy followed by a local treatment: pancreatic resection or radiation
Exclusion Criteria
-Allergy to iodine
-For any reason, the investigators think that the patient should not participate
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The number of detected liver metastasis
- Secondary Outcome Measures
Name Time Method - The rate of patients with the need to change treatment as a result of the exploration with NIR imaging<br>- The rate of patients with allergy for ICG<br>- The incidence of postoperative complications